Inflammatory arthritides of the spine: Surgical versus nonsurgical treatment

Clinical Orthopaedics and Related Research

Volumn 443, Issue , 2006, Pages 208-221

  Borenstein, David ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ARTHROTEC; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIFLUNISAL; ETANERCEPT; ETODOLAC; FLURBIPROFEN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; INFLIXIMAB; KETOPROFEN; LEFLUNOMIDE; MELOXICAM; METHOTREXATE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PIROXICAM; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; SULINDAC; UNINDEXED DRUG; ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; ARTHRODESIS; ATLANTOAXIAL SUBLUXATION; BACTERIAL INFECTION; CARDIOTOXICITY; CATARACT; CERVICAL SPINE; CERVICAL SPINE DISLOCATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIABETES MELLITUS; DIARRHEA; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EDEMA; FRAGILITY FRACTURE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; HYPERTENSION; INFECTION; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK HERNIA; JOINT DESTRUCTION; JOINT MOBILITY; LABORATORY TEST; LIGAMENT CALCINOSIS; LIVER TOXICITY; LOW BACK PAIN; LOW DRUG DOSE; MORNING STIFFNESS; OBESITY; OSTEOSYNTHESIS; OSTEOTOMY; PARESTHESIA; PATHOGENESIS; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RADICULAR PAIN; RANGE OF MOTION; RHEUMATOID ARTHRITIS; SPINE FRACTURE; SPINE FUSION; SPINE INSTABILITY; SPINE RADIOGRAPHY; SPINE STABILIZATION; SPINE SURGERY; SPONDYLOARTHROPATHY; STROKE; THROMBOSIS; TUBERCULOSIS; DECISION MAKING; METHODOLOGY; ORTHOPEDIC SURGERY; REVIEW; SPONDYLARTHRITIS;

ANTI-INFLAMMATORY AGENTS; DECISION MAKING; HUMANS; ORTHOPEDIC PROCEDURES; PHYSICAL THERAPY MODALITIES; SPONDYLARTHRITIS;

EID: 33645294159     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000200231.53695.92     Document Type: Conference Paper

References (82)

1. American College of Rheumatology Subcommittee on rheumatoid arthritis guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 2002;46:328-346.
2. Amor B, Dougados M, Mijiyama M. Criteria of the classification of spondyloarthropathies. Rev Rhum Mal Osteoartic. 1990;57:85-89.
3. Apple DF Jr, Anson C. Spinal cord injury occurring in patients with ankylosing spondylitis: a multicenter study. Orthopedics. 1995;18:1005-1011.
4. Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries FJ, Cooper NS, Healy LA, Kaplan SR, Liang MH, Luthra HS, Mesdger TA, Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid. Arthritis Rheum. 1988;31:315-324.
5. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343:1586-1593.
6. Bland JH, Van Buskirk FW, Tampas JP, Brown E, Clayton R. A study of roentgenographic criteria for rheumatoid arthritis of the cervical spine. AJR Am J Roentgenol. 1965;95:949-954.
7. Boden SD, Dodge LD, Bohlman HH, Rechtine GR. Rheumatoid arthritis of the cervical spine: a long term analysis with predictors of paralysis and recovery. J Bone Joint Surg. 1993;75A:1282-1289.
8. Bollow M, Enzweiler C, Taupitz M, Golder W, Hamm B, Sieper J, Braun J. Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. Clin Exp Rheumatol. 2002;20(Suppl 28):S167-S174.
9. Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum. 2003;48:1667-1675.
10. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sorensen H, Zeidler H, Thriene W, Sieper J. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet. 2002;359:1187-1193.
11. Braun J, Pham T, Sieper J, David J, van der Linden S, Dougados M, van der Heijde D, ASAS Working Group. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2003;62:817-824.
12. Braun J, Baraliakos X, Godolias G, Bohm H. Therapy of ankylosing spondylitis - a review. Part I: Conventional medical treatment and surgical therapy. Scand J Rheumatol. 2005;34:97-10.
13. Braun J, Baraliakos X, Brandt J, Sieper J. Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides. Scand J Rheumatol. 2005;34:178-190.
14. rd ed. Philadelphia, PA: Lippincott-Raven; 1998:721-732.
15. Broom MJ, Raycroft JF. Complications of fractures of the cervical spine in ankylosing spondylitis. Spine. 1988;13:763-766.
16. Cannon GW, Kremer JM. Leflunomide. Rheum Dis Clin North Am. 2004;30:295-310.
17. Chang MH, Liao KK, Cheung SC, Kong KW, Chang SP. "Numb, clumsy hands" and tactile agnosia secondary to high cervical spondylotic myelopathy: A clinical and electrophysiological correlation. Acta Neurol Scand. 1992;86:622-625.
18. Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907-916.
19. Christensson D, Saveland H, Rydholm U. Cervical spine surgery in rheumatoid arthritis: A Swedish nation-wide registration of 83 patients. Scand J Rheumatol. 2000;29:314-319.
20. Clegg DO, Reda D, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study. Arthritis Rheum. 1999;42:2325-2329.
21. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Treatment of rheumatoid arthritis with anakinra: A recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:614-624.
22. David J Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized controlled trial. Arthritis Rheum. 2003;48:3230-3236.
23. nd ed. Philadelphia, PA: Lippincott-Raven; 1997:845-870.
24. Detwiler KN, Loftus CM, Godersky JC, Menezes AH. Management of cervical spine injuries in patients with ankylosing spondylitis. J Neurosurg. 1990;72:210-215.
25. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H, The European Spondyloarthroplasty Study Group. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991;34:1218-1227.
26. Dougados M, Behier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum. 2001;44:180-185.
27. El Saghir H, Boehm H. Surgical options in the treatment of spinal disorders in ankylosing spondylitis. Clin Exp Rheumatol. 2002;20(Suppl 28):S101-S105.
28. Emery SE. Inflammatory Arthritis of the Spine. In: DeWald RL, Arlet V, Carl AL, O'Brien MF, eds. Spinal Deformities: The Comprehensive Text. New York, NY: Thieme; 2003:424-442.
29. Falkenbach A. Disability motivates patients with ankylosing spondylitis for more frequent physical exercise. Arch Phys Med Rehabil. 2003;84:382-383.
30. Fang D, Leong JCY, Ho EKN, Chan FL, Chow SP. Spinal pseudoarthrosis in ankylosing spondylitis: Clinicopathological correlations and results of anterior spinal fusion. J Bone Joint Surg. 1988;70B:443-447.
31. Fast A, Parikh S, Marin EL. Spine fractures in ankylosing spondylitis. Arch Phys Med Rehab. 1986;67:595-597.
32. Foo D, Sarkarati M, Marcelino V. Cervical spinal cord injury complicating ankylosing spondylitis. Paraplegia. 1985;23:358-365.
33. Fujiwara K, Fujimoto M, Owaki H, Kono J, Nakase T, Yonenobu K, Ochi T. Cervical lesions related to the systemic progression in rheumatoid arthritis. Spine. 1998;23:2052-2056.
34. rd ed. Edinburgh, Scotland: Mosby; 2003:765-780.
35. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002;346:1349-1356.
36. Graham B, Van Peteghern PK. Fractures of the spine in ankylosing spondylitis. Spine. 1989;14:803-807.
37. Grob D, Wursch R, Grauer W, Sturzenegger J, Dvorak J. Atlantoaxial fusion and retrodental pannus in rheumatoid arthritis. Spine. 1997;22:1580-1584.
38. Hermann KA, Althoff CE, Schneider U, Zuhlsdorf S, Lembcke A, Hamm B, Bollow M. Spinal changes in patients with spondyloarthritis: Comparison of MR imaging and radiographic appearances. Radiographics. 2005;25:559-570.
39. Kauppi M, Anttila P. A stiff collar can restrict atlantoaxial instability in rheumatoid atlantoaxial subluxations. Br J Rheumatol. 1996;35:771-774.
40. Keame J, Gershon S, Wise RP, Mirabile-Levens E, Kasnica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med. 2001;345:1098-1104.
41. nd ed. Philadelphia, PA: Lippincott-Raven; 1997:845-870.
42. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith CH. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis - an 8-month follow-up. J Rheumatol. 1994;21:261-263.
43. Law WA. Lumbar spinal osteotomy. J Bone Joint Surg. 1959;27B:1-11.
44. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903-911.
45. Lipsky PE, van der Heijde DMFM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343:1594-1602.
46. Macrae IF, Wright V. Measurement of back movement. Ann Rheum Dis. 1969;28:584-589.
47. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Infliximab (chimeric anti-tumor necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet. 1999;354:1932-1939.
48. McEwen C, DiTata D, Ling GC, Porini A, Good A, Rankin T. Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis, and Reiter's disease: A comparative study. Arthritis Rheum. 1971;14:291-318.
49. McMaster MJ. A technique for lumbar spinal osteotomy in ankylosing spondylitis. J Bone Joint Surg. 1985;67B:204-210.
50. McMaster MJ. Osteotomy of the cervical spine in ankylosing spondylitis. J Bone J Surg. 1997;79B:197-203.
51. Mehdian SMH, Freeman BJC, Licina P. Cervical osteotomy for ankylosing spondylitis: An innovative variation of an existing technique. Eur Spine J. 1999;8:505-509.
52. Miceli-Richard C, Dougados M. NSAIDs in ankylosing spondylitis. Clin Exp Rheumatol. 2002;20(Suppl 28):S65-S66.
53. Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME. Etanercept therapy in rheumatoid arthritis: a randomized controlled trial. Ann Intern Med. 1999;130:478-486.
54. Mukai Y, Hosono N, Sakaura H, Ishii T, Fuchiya T, Fijiwara K, Fuji T, Yoshikawa H. Laminoplasty for cervical myelopathy caused by subaxial lesions in rheumatoid arthritis. J Neurosurg. 2004;100:7-12.
55. Neva MH, Kauppi MJ, Kautiainen H, Luukkainen R, Hannonen P, Leirisalo-Repo M, Nissila M, Mottonen T, Fin-RaCo Trail Group. Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum. 2000;43:2397-2401.
56. Oostveen JCM, van de Laar M, Geelan JAG, de Graaff R. Successful conservative treatment of rheumatoid subaxial subluxation resulting in improvement of myelopathy, reduction of subluxation, and stabilization of the cervical spine. A report of two cases. Ann Rheum Dis. 1999;58:126-129.
57. Oostveen JCM, van de Laar MAFJ. Magnetic resonance imaging in rheumatic disorders of the spine and sacroiliac joints. Semin Arthritis Rheum. 2000;30:52-69.
58. Ostendorf B, Specker C, Schneider M. Methotrexate lacks efficacy in the treatment of severe ankylosing spondylitis compared with rheumatoid and psoriatic arthritis. J Clin Rheumatol. 1998;4:129-136.
59. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol. 1993;32(Suppl 1):4-14.
60. Ramos-Remus C, Gomez-Vargas A, Hernandez-Chavez A, Gamez-Nava JL, Gonzalez-Lopez L, Russell AS. Two-year follow-up of anterior and vertical atlantoaxial subluxations in ankylosing spondylitis. J Rheumatol. 1997;24:507-510.
61. Reiter MF, Boden SD. Inflammatory disorders of the cervical spine. Spine. 1998;23:2755-2766.
62. Rowed DW. Management of cervical spinal cord injury in ankylosing spondylitis: the intervertebral disc as a cause of cord compression. J Neurosurg. 1992;77:241-246.
63. Roychowdhury B, Bintley-Bagot S, Bulgen DY, Thompson RN, Tunn EJ, Moots RJ. Is methotrexate effective in ankylosing spondylitis? Rheumatol. 2002;41:1330-1332.
64. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704-706.
65. Shimzu K, Matsushita M, Fubayashi S, Toguchida J, Ido K, Nakamura T. Correction of kyphotic deformity of the cervical spine in ankylosing spondylitis using general anesthesia and internal fixation. J Spinal Dis. 1996;9:540-543.
66. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. JAMA. 2000;284:1247-1255.
67. Simmons EH. The surgical correction of flexion deformity of the cervical spine in ankylosing spondylitis. Clin Orthop Relat Res. 1972;86:132-143.
68. Spoorenberg A, van der Heijde, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26:980-984.
69. Surin VV. Fractures of the cervical spine in patients with ankylosing spondylitis. Acta Orthop Scand. 1980;51:79-84.
70. Szpalski M, Gunzburg R. What are the advances for surgical therapy of inflammatory disease of the spine. Best Pract Clin Rheumatol. 2002;16:141-154.
71. Tanaka N, Sakahashi H, Hirose K, Ishima T, Takahashi H, Ishii S. Results after 24 years of prophylactic surgery for rheumatoid arthritis atlantoaxial subluxation. J Bone Joint Surg. 2005;87B:955-958.
72. Thomassen E. Vertebral osteotomy for corrections of kyphosis in ankylosing spondylitis. Clin Orthop Relat Res. 1985;194:142-152.
73. van den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis alpha(infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum. 2002;46:755-765.
74. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-368.
75. van der Linden S, van Tubergen A, Hidding A. Physiotherapy in ankylosing spondylitis: What is the evidence? Clin Exp Rheumatol. 2002;20(Suppl 28):S60-S64.
76. Van Everdingen AA, Jacobs JWG, Siewertsz van Reesema DRS, Bijlisma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects. Ann Intern Med. 2002;136:1-12.
77. van Tubergen A, Boonen A, Landewe R, Rutten-Van Molken M, Van Der Heijde D, Hidding A, Van Der Linden S. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: A randomized controlled trial. Arthritis Rheum. 2002;47:459-467.
78. Wanders A, van der Heijde, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756-1765.
79. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Flieschmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ. A trial of etanercept, a recombinant tumor necrosis factor:Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253-259.
80. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis Rheum. 2003;48:35-45.
81. Zeidman SM, Ducker TB. Rheumatoid arthritis: neuroanatomy, compression, and grading of deficits. Spine. 1994;19:2259-2266.
82. Zeidman SM, Ducker TB, Raycroft J. Trends and complications in cervical spine surgery. 1989-1993. J Spine Dis. 1997;10:523-526.